Companies Cryptocurrencies
Imara Inc
Imara Inc
Exchange: NasdaqGS
IPO Date: 12/03/2020
CEO: Dr. Rahul D. Ballal Ph.D.
Biotechnology Healthcare 🔗
  • IMRA
    symbol
  • 6.95
    price
  • 122147640
    market cap
  • -0.3
    changes
If you bought

shares of Imara Inc (IMRA) on
You would have made
AMOUNT
today.
Old Price $12 Current Price $12

Imara, Inc. is a clinical-stage biopharmaceutical company. The Company is developing and commercializing therapeutics to treat patients suffering from rare inherited genetic disorders of hemoglobin. The Company’s product pipeline include IMR-687, which is an oral, once-a-day, potentially disease-modifying treatment for sickle cell disease (SCD), and beta-thalassemia. Its IMR-687 is a selective, small molecule inhibitor of phosphodiesterase-9 (PDE9). The Company is conducting a Phase 2a clinical trial of IMR-687 in adult patients with SCD and a Phase 2b clinical trial for the treatment of patients with beta-thalassemia.

Address: 116 HUNTINGTON AVENUE 6TH FLOOR Boston MASSACHUSETTS 02116

Stay updated.